Pierre-henri Benhamou

177-181 Avenue Pierre Brossolette
Montrouge, 92120, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.

Epicutaneous immunization using synthetic virus-like particles efficiently boosts protective immunity to respiratory syncytial virus.

Journal: Vaccine

Published: October 06, 2020

Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.

Epicutaneous Tolerance Induction to a Bystander Antigen Abrogates Colitis and Ileitis in Mice.

Journal: Inflammatory bowel diseases

Published: October 12, 2017

Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.

Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: July 28, 2016

Epicutaneous immunotherapy for food allergy as a novel pathway for oral tolerance induction.

Epicutaneous immunotherapy for food allergy as a novel pathway for oral tolerance induction.

Journal: Immunotherapy

Published: November 20, 2015

Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch.

Safety of epicutaneous immunotherapy for the treatment of peanut allergy: A phase 1 study using the Viaskin patch.

Journal: The Journal of allergy and clinical immunology

Published: October 15, 2015

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.

Differences in phenotype, homing properties and suppressive activities of regulatory T cells induced by epicutaneous, oral or sublingual immunotherapy in mice sensitized to peanut.

Journal: Cellular & molecular immunology

Published: October 08, 2015

Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.

Epicutaneous immunotherapy induces gastrointestinal LAP+ regulatory T cells and prevents food-induced anaphylaxis.

Journal: The Journal of allergy and clinical immunology

Published: September 17, 2015

Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept.

Needle-free and adjuvant-free epicutaneous boosting of pertussis immunity: Preclinical proof of concept.

Journal: Vaccine

Published: February 26, 2015

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

Specific epicutaneous immunotherapy prevents sensitization to new allergens in a murine model.

Journal: The Journal of allergy and clinical immunology

Published: February 06, 2014

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.

Intact skin and not stripped skin is crucial for the safety and efficacy of peanut epicutaneous immunotherapy (EPIT) in mice.

Journal: Clinical and translational allergy

Published: July 12, 2012

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

Epicutaneous Immunotherapy Compared with Sublingual Immunotherapy in Mice Sensitized to Pollen (Phleum pratense).

Journal: ISRN allergy

Published: December 19, 2011

Showing 1-11 of 11

Last Updated: 09/26/2026